BURE EQUITY AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 370.8 SEK | -0.54% |
|
+1.70% | +29.74% |
| 13/05 | Bure Equity AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 07/05 | Bure Equity AB Approves Ordinary Dividend for the 2023 Financial Year, Payable on 15 May 2024 | CI |
| Sales 2022 | -917.3Cr -87Cr -7.25TCr | Sales 2023 | 480.8Cr 46Cr 3.8TCr | Capitalization | 2.12TCr 200.68Cr 17TCr |
|---|---|---|---|---|---|
| Net income 2022 | -924.3Cr -88Cr -7.31TCr | Net income 2023 | 474.5Cr 45Cr 3.75TCr | EV / Sales 2022 | -1.93 x |
| Net cash position 2022 | 53Cr 5.01Cr 418.24Cr | Net cash position 2023 | 157.3Cr 15Cr 1.24TCr | EV / Sales 2023 | 4.08 x |
| P/E ratio 2022 |
-1.98
x | P/E ratio 2023 |
4.47
x | Employees | 11 |
| Yield 2022 |
0.91% | Yield 2023 |
0.87% | Free-Float | 70.61% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.43% | ||
| 1 week | +1.92% | ||
| Current month | +1.81% | ||
| 1 month | -0.43% | ||
| 3 months | +10.40% | ||
| 6 months | +34.54% | ||
| Current year | +30.02% |
1 week
363.80
372.80
1 month
354.00383.00
Current year
272.40383.00
1 year
202.20383.00
3 years
171.30489.20
5 years
126.40489.20
10 years
26.40489.20
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/99/01 | |
Max Jonson
DFI | Director of Finance/CFO | 56 | 01/13/01 |
| Chairman | 60 | 01/99/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 01/19/01 | |
| Chairman | 60 | 01/99/01 | |
| Director/Board Member | 70 | 10/16/10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.22% | 262 M€ | +12.61% | ||
| 0.01% | 775 M€ | -.--% | - | |
| 0.01% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/24/10 | 370.8 | -0.54% | 61 081 |
| 07/24/07 | 372.8 | +0.87% | 48,754 |
| 05/24/05 | 369.6 | +0.54% | 36,351 |
| 04/24/04 | 367.6 | +0.82% | 54,834 |
| 03/24/03 | 364.6 | -0.11% | 45,395 |
Delayed Quote Nasdaq Stockholm, June 10, 2024 at 01:30 pm IST
More quotes
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Sector
Investment Holding Companies
Calendar
16/08/2024
- Q2 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +30.02% | 262.26Cr | |
| +23.71% | 8.37TCr | |
| +13.27% | 1.8TCr | |
| +48.94% | 1.67TCr | |
| +10.98% | 1.5TCr | |
| -3.14% | 1.26TCr | |
| +9.65% | 1.12TCr | |
| +27.75% | 1.01TCr | |
| -3.05% | 967.69Cr | |
| +66.35% | 854.68Cr |
- Stock Market
- Equities
- BURE Stock
